Stock Groups

Which Veterinary Stock is a Better Buy? -Breaking

by Mike Robinson

[ad_1]

© Reuters. IDEXX Laboratories vs. Siemens Healthineers – Which Veterinary Stock Is a Better Investment?

In the midst of this pandemic, veterinary firms have seen solid growth due to increased pet adoptions and higher animal care expenditures. And we think two prominent industry participants, Siemens Healthineers (SMMNY) and IDEXX Laboratories (IDXX), should benefit from the industry’s long-term growth prospects. Which stock is better to buy right now? Find out more. The two leading players in the diagnostics-and research sector are IDEXX Laboratories, Inc. in Westbrook, Maine, and Siemens Healthineers AG in Erlangen, Germany. SMMNY, a medical technology firm, operates across four divisions: Imaging; Diagnostics; Varian. Advanced Therapies. It offers medical technology services and equipment performance management. IDXX is a manufacturer and distributor of products, as well as providing services in the water and dairy testing, companion animal, veterinarian, poultry and livestock markets. It also offers portable electrolytes for human diagnostics and blood gas analyzers.

The industry’s record profits were made last year thanks to a significant rise in pet adoption and increased expenditure on healthcare for companion and production animals. Companies have been incentivized to create new and more effective drugs, vaccines and diagnostic devices as well as pet-friendly products, and digitize their vet services.

Rising investor optimism surrounding the industry’s prospects is evident in the ProShares Pet Care ETF’s (PAWZ) 30.8% gains over the past year versus the Health Care Select Sector SPDR Fund’s (XLV) 22.3% gains. By 2028, the global veterinary market will grow by 5.4% to $114.40billion. Both SMMNY as IDXX will be able to reap the benefits.

Continue reading on StockNews

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information, including buy/sell signal data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]